Destiny Pharma Expert View Published in The Pharma Letter
Wednesday August 24, 2016
Wednesday August 24, 2016
CEO, Dr Bill Love discusses the rise in MRSA and MSSA in the UK’s NHS in this week’s Expert View in The Pharma Letter. To view the article, please click here